BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 25635914)

  • 1. Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens.
    Andersen JL; He GX; Kakarla P; K C R; Kumar S; Lakra WS; Mukherjee MM; Ranaweera I; Shrestha U; Tran T; Varela MF
    Int J Environ Res Public Health; 2015 Jan; 12(2):1487-547. PubMed ID: 25635914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial Multidrug Efflux Pumps of the Major Facilitator Superfamily as Targets for Modulation.
    Kumar S; He G; Kakarla P; Shrestha U; Ranjana KC; Ranaweera I; Willmon TM; Barr SR; Hernandez AJ; Varela MF
    Infect Disord Drug Targets; 2016; 16(1):28-43. PubMed ID: 27052334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for efflux pump systems of bacteria by the new acridine orange agar method.
    Martins A; Amaral L
    In Vivo; 2012; 26(2):203-6. PubMed ID: 22351659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efflux-mediated drug resistance in bacteria.
    Li XZ; Nikaido H
    Drugs; 2004; 64(2):159-204. PubMed ID: 14717618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of antimicrobial efflux pumps of the major facilitator superfamily in
    Lekshmi M; Ammini P; Adjei J; Sanford LM; Shrestha U; Kumar S; Varela MF
    AIMS Microbiol; 2018; 4(1):1-18. PubMed ID: 31294201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MDR efflux pumps and antimicrobial resistance].
    Sánchez Díaz P
    Rev Esp Quimioter; 2003 Jun; 16(2):172-87. PubMed ID: 12973455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized efflux assay for the NorA multidrug efflux pump in Staphylococcus aureus.
    Zimmermann S; Tuchscherr L; Rödel J; Löffler B; Bohnert JA
    J Microbiol Methods; 2017 Nov; 142():39-40. PubMed ID: 28887002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Active efflux as the multidrug resistance mechanism].
    Wasaznik A; Grinholc M; Bielawski KP
    Postepy Hig Med Dosw (Online); 2009 Apr; 63():123-33. PubMed ID: 19373193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of bacterial efflux pumps in biofilm formation.
    Alav I; Sutton JM; Rahman KM
    J Antimicrob Chemother; 2018 Aug; 73(8):2003-2020. PubMed ID: 29506149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efflux pumps: their role in Staphylococcus aureus antibiotic resistance].
    Doléans-Jordheim A; Michalet S; Bergeron E; Boisset S; Souard F; Dumontet C; Dijoux-Franca MG; Freney J
    Ann Biol Clin (Paris); 2008; 66(5):499-508. PubMed ID: 18957338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug-resistance efflux pumps - not just for resistance.
    Piddock LJ
    Nat Rev Microbiol; 2006 Aug; 4(8):629-36. PubMed ID: 16845433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of forty new phenothiazine derivatives for activity against intrinsic efflux pump systems of reference Escherichia coli, Salmonella Enteritidis, Enterococcus faecalis and Staphylococcus aureus strains.
    Takács D; Cerca P; Martins A; Riedl Z; Hajós G; Molnár J; Viveiros M; Couto I; Amaral L
    In Vivo; 2011; 25(5):719-24. PubMed ID: 21753124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of Vibrio vulnificus RND efflux pumps homologous to Vibrio cholerae VexAB and VexCD, and to Escherichia coli AcrAB.
    Lee S; Yeom JH; Seo S; Lee M; Kim S; Bae J; Lee K; Hwang J
    J Microbiol; 2015 Apr; 53(4):256-61. PubMed ID: 25740377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation and physiological function of multidrug efflux pumps in Escherichia coli and Salmonella.
    Nishino K; Nikaido E; Yamaguchi A
    Biochim Biophys Acta; 2009 May; 1794(5):834-43. PubMed ID: 19230852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding efflux in Gram-negative bacteria: opportunities for drug discovery.
    Schweizer HP
    Expert Opin Drug Discov; 2012 Jul; 7(7):633-42. PubMed ID: 22607346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the multidrug efflux pump EmrD-3 from Vibrio cholerae by Allium sativum extract and the bioactive agent allyl sulfide plus synergistic enhancement of antimicrobial susceptibility by A. sativum extract.
    Bruns MM; Kakarla P; Floyd JT; Mukherjee MM; Ponce RC; Garcia JA; Ranaweera I; Sanford LM; Hernandez AJ; Willmon TM; Tolson GL; Varela MF
    Arch Microbiol; 2017 Oct; 199(8):1103-1112. PubMed ID: 28432381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of multidrug resistant efflux systems in bacteria.
    Zechini B; Versace I
    Recent Pat Antiinfect Drug Discov; 2009 Jan; 4(1):37-50. PubMed ID: 19149695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocide Selective TolC-Independent Efflux Pumps in Enterobacteriaceae.
    Slipski CJ; Zhanel GG; Bay DC
    J Membr Biol; 2018 Feb; 251(1):15-33. PubMed ID: 29063140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the multidrug efflux pump LmrS from Staphylococcus aureus by cumin spice Cuminum cyminum.
    Kakarla P; Floyd J; Mukherjee M; Devireddy AR; Inupakutika MA; Ranweera I; Kc R; 'Shrestha U; Cheeti UR; Willmon TM; Adams J; Bruns M; Gunda SK; Varela MF
    Arch Microbiol; 2017 Apr; 199(3):465-474. PubMed ID: 27830269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.